Bioactive compounds of Aspergillus terreus—F7, an endophytic fungus from Hyptis suaveolens (L.) Poit
- 372 Downloads
The compounds terrein (1), butyrolactone I (2), and butyrolactone V (3) were isolated from the ethyl acetate extract (EtOAc) of the endophytic fungus Aspergillus terreus—F7 obtained from Hyptis suaveolens (L.) Poit. The extract and the compounds presented schistosomicidal activity against Schistosoma mansoni; at 100 µg/mL for EtOAc extract, 1297.3 µM for compound 1, 235.6 µM for compound 2, and 454.1 µM for compound 3, they killed 100% of the parasites after 72 h of treatment. Compounds 1, 2, and 3 exerted moderate leishmanicidal activity against Leishmania amazonensis (IC50 ranged from 23.7 to 78.6 µM). At 235.6 and 227.0 µM, compounds 2 and 3, respectively, scavenged 95.92 and 95.12% of the DPPH radical (2,2-diphenyl-1-picryl-hydrazyl), respectively. Regarding the cytotoxicity against the breast tumor cell lines MDA-MB-231 and MCF-7, compound 2 gave IC50 of 34.4 and 17.4 µM, respectively, while compound 3 afforded IC50 of 22.2 and 31.9 µM, respectively. At 117.6 µM, compound 2 inhibited the growth of and killed the pathogen Escherichia coli (ATCC 25922). Compounds 1, 2, and 3 displayed low toxicity against the normal line of human lung fibroblasts (GM07492A cells), with IC50 of 15.3 × 103, 3.4 × 103, and 5.8 × 103 µM, respectively. This is the first report on (i) the in vitro schistosomicidal and leishmanicidal activities of the EtOAc extract of A. terreus—F7 and compounds 1, 2, and 3; and (ii) the antitumor activity of compounds 2 and 3 against MDA-MB-231 and MCF-7 cells.
KeywordsAntioxidant Antitumor Butyrolactones Leishmanicidal Schistosomicidal Terrein
The authors thank to the National Council for Scientific and Technological Development (CNPq) (Grant No. 552240/2011-7), Coordination for the Improvement of Higher Education Personnel (CAPES), and National Institute of Science and Technology in Wetlands (INAU) for institutional and financial support.
- Barton DHR, Miller E (1955) The constitution and stereochemistry of terrein. J Chem Soc 1028–1029. doi: 10.1039/JR9550001028
- Birch AJ, Cassera A, Jones AR (1965) The biosynthesis of terrein. Chem Commun 9:167–168Google Scholar
- Campos FF, Sales Junior PA, Romanha AJ, Araújo MS, Siqueira EP, Resende JM, Alves TM, Martins-Filho OA, Santos VL, Rosa CA, Zani CL, Cota BB (2015) Bioactive endophytic fungi isolated from Caesalpinia echinata Lam. (Brazilwood) and identification of beauvericin as a trypanocidal metabolite from Fusarium sp. Mem Inst Oswaldo Cruz 110:65–74CrossRefGoogle Scholar
- Dewi RT, Tachibana S, Darmawan A (2012) Antidiabetic and antioxidative activities of butyrolactone I from Aspergillus terreus. WASET 6:818–823Google Scholar
- Grove JF (1954) The structure of terrein. J Chem Soc 4693–4694Google Scholar
- Hormazabal E, Schmeda-Hirschmann G, Astudillo L, Rodríguez J, Theoduloz C (2005) Metabolites from Microsphaeropsis olivacea, an endophytic fungus of Pilgerodendron uviferum. Z Naturforsch, C. J Biosci 60:11–21Google Scholar
- Jayanthi G, Kamalraja S, Karthikeyanb K, Muthumarya J (2011) Antimicrobial and antioxidant activity of the endophytic fungus Phomopsis sp. GJJM07 isolated from Mesua ferrea. Int J Curr Sci 1:85–90Google Scholar
- Nishio K, Ishida T, Arioka H, Kurokawa H, Fukuoka K, Nomoto T, Fukumoto H, Yokote H, Saijo N (1996) Antitumor effects of butyrolactone I, a selective cdc2 kinase inhibitor, on human lung cancer cell lines. Anticancer Res 16:3387–3395Google Scholar
- Shibata A, Ibaragi S, Mandai H, Tsumura T, Kishimoto K, Okui T, Hassan NM, Shimo T, Omori K, Hu GF, Takashiba S, Suga S, Sasaki A (2016) Synthetic terrein inhibits progression of head and neck cancer by suppressing angiogenin production. Anticancer Res 36:2161–2168Google Scholar
- Zhang F, Mijiti M, Ding W, Song J, Yin Y, Sun W, Li Z (2015a) (+)-Terrein inhibits human hepatoma Bel-7402 proliferation through cell cycle arrest. Oncol Rep 33:1191–1200Google Scholar